Editas Medicine Announces Publication in Nature Medicine of Data Supporting the Development of EDIT-101
Editas Medicine Announces U.S. Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR Interference
Editas Medicine Announces Exclusive License to Advanced CRISPR Genome Editing Technology from Massachusetts General Hospital
SAGA Metals Extends Claims at the Radar Ti-V-Fe Project --Securing the Entire Titanomagnetite-Bearing Intrusion
Significant intercepts of gold and copper show Golden Eye emerging as a highly promising new resource prospect
Alvopetro Announces an Operational Update, Q1 2025 Financial Results and Details for our Upcoming AGM